FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043952466> ?p ?o ?g. }

• W3043952466 endingPage "736" @default.
• W3043952466 startingPage "725" @default.
• W3043952466 abstract "This study comprehensively evaluated the association between known circulating tumor necrosis factor (TNF) superfamily ligands and receptors and the development of early progressive kidney decline (PKD) leading to end-stage kidney disease (ESKD) in Type 1 diabetes. Participants for the study were from the Macro-Albuminuria Study (198 individuals), and the Micro-Albuminuria Study (148 individuals) of the Joslin Kidney Study. All individuals initially had normal kidney function and were followed for seven-fifteen years to determine the slope of the estimate glomerular filtration rate and to ascertain onset of ESKD. Plasma concentrations of 25 TNF superfamily proteins were measured using proximity extension assay applied in the OLINK proteomics platform. In the both studies risk of early PKD, determined as estimated glomerular filtration rate loss greater than or equal to three ml/min/1.73m2/year, was associated with elevated circulating levels of 13 of 19 TNF receptors examined. In the Macro-Albuminuria Study, we obtained similar findings for risk of progression to ESKD. These receptors comprised: TNF-R1A, -R1B, -R3, -R4, -R6, -R6B, -R7, -R10A, -R10B, -R11A, -R14, -R21, and -R27. Serial measurements showed that circulating levels of these TNF receptors had increased before the onset of PKD. In contrast, none of the six measured TNF ligands showed association with risk of early PKD. Of significance, the disease process that underlies PKD leading to ESKD in Type 1 diabetes has a profile also seen in autoimmune disorders. The mechanisms of this enrichment may be causally related to the development of PKD in Type 1 diabetes and must be investigated further. Thus, some of these receptors may be used as new risk predictors of ESKD. This study comprehensively evaluated the association between known circulating tumor necrosis factor (TNF) superfamily ligands and receptors and the development of early progressive kidney decline (PKD) leading to end-stage kidney disease (ESKD) in Type 1 diabetes. Participants for the study were from the Macro-Albuminuria Study (198 individuals), and the Micro-Albuminuria Study (148 individuals) of the Joslin Kidney Study. All individuals initially had normal kidney function and were followed for seven-fifteen years to determine the slope of the estimate glomerular filtration rate and to ascertain onset of ESKD. Plasma concentrations of 25 TNF superfamily proteins were measured using proximity extension assay applied in the OLINK proteomics platform. In the both studies risk of early PKD, determined as estimated glomerular filtration rate loss greater than or equal to three ml/min/1.73m2/year, was associated with elevated circulating levels of 13 of 19 TNF receptors examined. In the Macro-Albuminuria Study, we obtained similar findings for risk of progression to ESKD. These receptors comprised: TNF-R1A, -R1B, -R3, -R4, -R6, -R6B, -R7, -R10A, -R10B, -R11A, -R14, -R21, and -R27. Serial measurements showed that circulating levels of these TNF receptors had increased before the onset of PKD. In contrast, none of the six measured TNF ligands showed association with risk of early PKD. Of significance, the disease process that underlies PKD leading to ESKD in Type 1 diabetes has a profile also seen in autoimmune disorders. The mechanisms of this enrichment may be causally related to the development of PKD in Type 1 diabetes and must be investigated further. Thus, some of these receptors may be used as new risk predictors of ESKD." @default.
• W3043952466 created "2020-07-29" @default.
• W3043952466 creator A5001791944 @default.
• W3043952466 creator A5003347831 @default.
• W3043952466 creator A5005824874 @default.
• W3043952466 creator A5010470844 @default.
• W3043952466 creator A5038456538 @default.
• W3043952466 creator A5045404629 @default.
• W3043952466 creator A5046427137 @default.
• W3043952466 creator A5049233186 @default.
• W3043952466 creator A5075863437 @default.
• W3043952466 creator A5081727479 @default.
• W3043952466 date "2021-03-01" @default.
• W3043952466 modified "2023-09-27" @default.
• W3043952466 title "A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders" @default.
• W3043952466 cites W1492754188 @default.
• W3043952466 cites W1517251865 @default.
• W3043952466 cites W1967645443 @default.
• W3043952466 cites W1974450923 @default.
• W3043952466 cites W1979445622 @default.
• W3043952466 cites W1980876617 @default.
• W3043952466 cites W1988158890 @default.
• W3043952466 cites W1989219560 @default.
• W3043952466 cites W2006538317 @default.
• W3043952466 cites W2010084870 @default.
• W3043952466 cites W2013698876 @default.
• W3043952466 cites W2015549055 @default.
• W3043952466 cites W2022234093 @default.
• W3043952466 cites W2023508968 @default.
• W3043952466 cites W2036785641 @default.
• W3043952466 cites W2037958421 @default.
• W3043952466 cites W2044202348 @default.
• W3043952466 cites W2046012831 @default.
• W3043952466 cites W2048356493 @default.
• W3043952466 cites W2061625478 @default.
• W3043952466 cites W2064336305 @default.
• W3043952466 cites W2074881372 @default.
• W3043952466 cites W2075929587 @default.
• W3043952466 cites W2081529759 @default.
• W3043952466 cites W2094371537 @default.
• W3043952466 cites W2098933194 @default.
• W3043952466 cites W2099265537 @default.
• W3043952466 cites W2105076697 @default.
• W3043952466 cites W2112744022 @default.
• W3043952466 cites W2112894886 @default.
• W3043952466 cites W2114853101 @default.
• W3043952466 cites W2115034481 @default.
• W3043952466 cites W2120970466 @default.
• W3043952466 cites W2123830992 @default.
• W3043952466 cites W2123838494 @default.
• W3043952466 cites W2129139560 @default.
• W3043952466 cites W2134163777 @default.
• W3043952466 cites W2134643174 @default.
• W3043952466 cites W2134676775 @default.
• W3043952466 cites W2137536099 @default.
• W3043952466 cites W2149719081 @default.
• W3043952466 cites W2151053450 @default.
• W3043952466 cites W2160026989 @default.
• W3043952466 cites W2322889089 @default.
• W3043952466 cites W2339919335 @default.
• W3043952466 cites W2460943792 @default.
• W3043952466 cites W2540847774 @default.
• W3043952466 cites W2585466245 @default.
• W3043952466 cites W2592820806 @default.
• W3043952466 cites W2605121685 @default.
• W3043952466 cites W2611937140 @default.
• W3043952466 cites W2620769476 @default.
• W3043952466 cites W2788380006 @default.
• W3043952466 cites W2898567584 @default.
• W3043952466 cites W2922265282 @default.
• W3043952466 cites W2939798759 @default.
• W3043952466 cites W2975540430 @default.
• W3043952466 cites W4253079783 @default.
• W3043952466 doi "https://doi.org/10.1016/j.kint.2020.07.007" @default.
• W3043952466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7891866" @default.
• W3043952466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32717193" @default.
• W3043952466 hasPublicationYear "2021" @default.
• W3043952466 type Work @default.
• W3043952466 sameAs 3043952466 @default.
• W3043952466 citedByCount "9" @default.
• W3043952466 countsByYear W30439524662021 @default.
• W3043952466 countsByYear W30439524662022 @default.
• W3043952466 countsByYear W30439524662023 @default.
• W3043952466 crossrefType "journal-article" @default.
• W3043952466 hasAuthorship W3043952466A5001791944 @default.
• W3043952466 hasAuthorship W3043952466A5003347831 @default.
• W3043952466 hasAuthorship W3043952466A5005824874 @default.
• W3043952466 hasAuthorship W3043952466A5010470844 @default.
• W3043952466 hasAuthorship W3043952466A5038456538 @default.
• W3043952466 hasAuthorship W3043952466A5045404629 @default.
• W3043952466 hasAuthorship W3043952466A5046427137 @default.
• W3043952466 hasAuthorship W3043952466A5049233186 @default.
• W3043952466 hasAuthorship W3043952466A5075863437 @default.
• W3043952466 hasAuthorship W3043952466A5081727479 @default.
• W3043952466 hasBestOaLocation W30439524662 @default.
• W3043952466 hasConcept C126322002 @default.
• W3043952466 hasConcept C134018914 @default.
• W3043952466 hasConcept C159641895 @default.

• next